First Trust Direct Indexing’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-60,910
| Closed | -$968K | – | 706 |
|
|
2024
Q3 | $968K | Buy |
60,910
+3,890
| +7% | +$61.8K | 0.05% | 354 |
|
|
2024
Q2 | $869K | Buy |
57,020
+3,850
| +7% | +$58.7K | 0.05% | 345 |
|
|
2024
Q1 | $780K | Buy |
53,170
+1,255
| +2% | +$18.4K | 0.06% | 350 |
|
|
2023
Q4 | $722K | Buy |
51,915
+6,130
| +13% | +$85.3K | 0.06% | 342 |
|
|
2023
Q3 | $612K | Buy |
45,785
+4,570
| +11% | +$61.1K | 0.07% | 336 |
|
|
2023
Q2 | $520K | Sell |
41,215
-685
| -2% | -$8.65K | 0.06% | 402 |
|
|
2023
Q1 | $477K | Buy |
41,900
+5,845
| +16% | +$66.6K | 0.06% | 412 |
|
|
2022
Q4 | $373K | Buy |
36,055
+6,010
| +20% | +$62.2K | 0.05% | 452 |
|
|
2022
Q3 | $315K | Buy |
30,045
+2,855
| +11% | +$29.9K | 0.05% | 453 |
|
|
2022
Q2 | $301K | Buy |
27,190
+3,110
| +13% | +$34.4K | 0.04% | 469 |
|
|
2022
Q1 | $268K | Buy |
24,080
+1,720
| +8% | +$19.1K | 0.03% | 537 |
|
|
2021
Q4 | $293K | Sell |
22,360
-500
| -2% | -$6.55K | 0.04% | 498 |
|
|
2021
Q3 | $298K | Sell |
22,860
-4,285
| -16% | -$55.9K | 0.04% | 474 |
|
|
2021
Q2 | $399K | Buy |
+27,145
| New | +$399K | 0.06% | 384 |
|